Gene · 3073
Papers1,522
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,522
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma. | J Transl Med | 2023 | 37848935 | PubTator, text mining | PubMed |
| Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis. | Int J Mol Sci | 2023 | 37834060 | PubTator, text mining | PubMed |
| Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction. | Nat Commun | 2023 | 37833292 | PubTator, text mining | PubMed |
| An evidence-informed policymaking (EIPM) competency profile for the Brazilian Health System developed through consensus: process and outcomes. | Health Res Policy Syst | 2023 | 37828575 | PubTator, text mining | PubMed |
| Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates. | Sci Rep | 2023 | 37779126 | PubTator, text mining | PubMed |
| Effect of changes in sleeping behavior on skeletal muscle and fat mass: a retrospective cohort study. | BMC Public Health | 2023 | 37770876 | PubTator, text mining | PubMed |
| Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach. | Cancers (Basel) | 2023 | 37760635 | PubTator, text mining | PubMed |
| Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options. | Cells | 2023 | 37759536 | PubTator, text mining | PubMed |
| Salivary Chemical Barrier Proteins in Oral Squamous Cell Carcinoma-Alterations in the Defense Mechanism of the Oral Cavity. | Int J Mol Sci | 2023 | 37686462 | PubTator, text mining | PubMed |
| Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variants. | Orphanet J Rare Dis | 2023 | 37670342 | PubTator, text mining | PubMed |
| The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial. | BMC Med Res Methodol | 2023 | 37667204 | PubTator, text mining | PubMed |
| Phage-assisted evolution and protein engineering yield compact, efficient prime editors. | Cell | 2023 | 37657419 | PubTator, text mining | PubMed |
| Molecular Design Strategy of Protein Isoform-Specific Fluorescent Probes by Considering Molecule in Its Entirety. | Anal Chem | 2023 | 37649365 | PubTator, text mining | PubMed |
| Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations. | Int J Mol Sci | 2023 | 37629187 | PubTator, text mining | PubMed |
| Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification. | Biomolecules | 2023 | 37627292 | PubTator, text mining | PubMed |
| Nursing Care Plan for Patients with Tay-Sachs-A Rare Paediatric Disease. | J Pers Med | 2023 | 37623472 | PubTator, text mining | PubMed |
| High genetic heterogeneity of leukodystrophies in Iranian children: the first report of Iranian Leukodystrophy Registry. | Neurogenetics | 2023 | 37597066 | PubTator, text mining | PubMed |
| Long-range PCR amplification-based targeted enrichment & next generation sequencing: A cost-effective testing strategy for lysosomal storage disorders. | Indian J Med Res | 2023 | 37530313 | PubTator, text mining | PubMed |
| The Etiological Profile of Global Developmental Delay at a Tertiary Care Hospital in India: An Observational Study. | Cureus | 2023 | 37519562 | PubTator, text mining | PubMed |
| Stereoselective Synthesis of Heavily Hydroxylated Azepane Iminosugars via Osmium-Catalyzed Tethered Aminohydroxylation. | Org Lett | 2023 | 37515782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3073/papers?page=6